摘要
如今器官移植已经成为现代医学治疗的重要手段之一,但是移植产生的排斥反应给患者的治疗带来了极大的风险。免疫抑制剂的使用有效地抑制了这种危险,并提高了器官移植的成功率。其中,微生物产生的免疫抑制剂占据了绝大部分市场份额。另外,随着生物技术的不断应用,微生物来源的免疫抑制剂新品种的不断涌现给进行器官移植的患者带来了福音。本文分析了该类免疫抑制剂的国内外生产状况、研发进展及市场信息,以期为相关企业制定营销战略决策起导向作用。
Currently organ transplantation has been applied as one of the important means of medical treatment,but allograft rejection has brought great risk to patients.The use of immunosuppressive agents has restrained the danger and increased the success rate of organ transplantation.Among these agents,the immunosuppressive agents from microorganisms had made up an absolute share in the market.In addition,with the continuous application of biotechnology,the introductions of new products had brought good news to patients with organ transplantation.The production situation,RD progress and market information of immunosuppressive agents were analyzed in detail.We expect to provide references for the relevant enterprises and government departments to formulate business strategies.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2011年第2期129-136,共8页
Chinese Journal of New Drugs
关键词
微生物
免疫抑制剂
国内外
生产情况
研发进展
市场分析
microorganism
immunosuppressive agents
abroad and home
production situation
R＆D progress
market analysis
